MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Shivam Chemicals Ltd › Subscription
SH
Shivam Chemicals Ltd
CLOSED BSE SME Fixed Price IPO Fresh Capital Shivam Chemicals IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹44
Issue Price: ₹ 44
Issue Price
₹44
Face Value
₹10
Lot Size
3,000 shares
Open Date
23 Apr 2024
Close Date
25 Apr 2024
Allotment
26 Apr 2024
Listing Date
30 Apr 2024
Exchange
BSE SME

Shivam Chemicals IPO Details: Price, Dates & Financials

The Shivam Chemicals IPO GMP strength score is 7.5 out of 10, which the dashboard rates as Good. The Shivam Chemicals IPO valuation is tagged Weak. The Shivam Chemicals IPO NII/HNI category is reserved for 47.48% of the offer. The Shivam Chemicals IPO Retail (RII) category is reserved for 47.48% of the offer. Live subscription numbers for the Shivam Chemicals IPO are not yet available, and amounts are calculated at the upper price band of ₹44.

IPO Analytics Dashboard
LIVE
Shivam Chemicals IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Weak
Shivam Chemicals IPO GMP Strength Score
8 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Shivam Chemicals IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 2,178,000 (47%) —
👤 Retail (RII) — 2,178,000 (47%) —
📊 Market Maker — 231,000 (5%) —
Σ Total — 4,587,000 (100%) —

* Amount calculated at upper price band (₹44) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 2,178,000 (47%)
47%
👤
Retail (RII) ? 2,178,000 (47%)
47%
📊
Market Maker ? 231,000 (5%)
5%
Total Shares Offered 4,587,000 (100%)
Shivam Chemicals IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 3,000
Min. Investment ₹132,000
💼 HNI Investors ?
Min. Lots 2
Min. Shares 6,000
Min. Investment ₹264,000
Shivam Chemicals IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 3
Post-Issue EPS ?
₹ 1
Pre-Issue P/E ?
15 x
Post-Issue P/E ?
79 x
Shivam Chemicals IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 29 Apr 2024
  2. 2 📂 Credit of Shares to Demat 29 Apr 2024
Investor Interpretation
  • Retail allocation is strong at 47% of the total offering.
  • HNI/NII demand is strong at 47%.
  • The IPO P/E of 79x reflects a weak valuation relative to typical market ranges.
  • Pre-issue EPS of ₹3 compares to post-issue EPS of ₹1 after dilution.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

Shivam Chemicals IPO Subscription FAQs
Subscription data for Shivam Chemicals IPO is not available right now. Numbers are updated here during the bidding window.
In Shivam Chemicals IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹132,000); HNI/sNII minimum 2 lots (₹₹264,000).
Shares offered by category — Retail 2,178,000 (47%) shares.
Shivam Chemicals IPO valuation — pre-issue EPS ₹2.88, post-issue EPS ₹0.56, pre-issue P/E 15.26, post-issue P/E 79.19.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Shivam Chemicals IPO's NII and HNI subscription levels helps investors assess demand for the Shivam Chemicals IPO and overall investor interest.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.